News About: Pharm. Industry
Kim Young-Ran Law makes 2 of 3 pharmas cut entertainment expenses
The Anti-Corruption and Bribery Prohibition Law enforced on 28 September 2016, also known as the ‘Kim Young-Ran Law’ reportedly made pharmaceutical companies reduce entertainment expenses significantly.
Since people,...
1 of 3 listed pharmas records operating profit ratio higher than 10%
1 of 3 listed pharmaceutical companies passed 10% in operating profit, and there were reportedly 10 pharmaceutical companies having an operating profit ratio less than 3%, which is what a pharmaceutical distribution c...
JW Pharmaceutical, Otsuka and Hanlim selected as excellent innovative pharmaceutical company of 2017
The government has selected JW Pharmaceutical, Korea Otsuka Pharmaceutical and Hanlim Pharm as the excellent innovative pharmaceutical company of 2017.
On the 17th, the Ministry of Health and Welfare(Minister Neung-H...
Innovation and changes… Sanofi’s efforts for its life partners‘Sanofi,’ the only innovative pharmaceutical company among the top 10 global health care companies branching in Korea, made a new resolution to continue innovation.
At a press ...
|
Listed pharmas’ secret of profitability increase is financial reduction in SG&A
It was analyzed pharmaceutical companies’ profitability has increased because they reduced selling, general & administrative(SG&A) expenses. In 1 of 3 listed pharmaceutical companies, however, their SG&A expenses whic...
Government’s R&D support to focus on private investments
“We not only will enlarge the governmental R&D support, but is planning to enhance our policy, such as tax benefits, focusing on promoting private investments.”
Hosted by the Ministry of Health and Welfare(MOHW) and ...
Listed pharmas taking steps back in R&D investment
Listed pharmaceutical companies were criticized that they took a step back in R&D investment.
Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmaceutical companies’ 2017 3rd quarter business perform...
Disposal of CJ HealthCare, who will purchase its value and potential?
After the CJ HealthCare’s announcement of disposal, no one has made a move yet, which created various talks.
Key points that the industry have mentioned are if the company will be well disposed as the CJ HealthCare o...
Government’s support plans from novel drug development using AI to tax benefits
The government’s widely ranged plans to support the pharmaceutical industry has started to be visualized from R&D(smart clinical study platforms and artificial intelligence for novel drug development), trainings for t...
Listed pharmas’ decent external business growth
Listed pharmaceutical companies were evaluated having a decent business performance this year, but sales gaps between the companies were intensified.
1 of 3 listed pharmaceutical companies had a decrease in operating...
